nodes	percent_of_prediction	percent_of_DWPC	metapath
Amantadine—Parkinson's disease—Bromocriptine—type 2 diabetes mellitus	0.538	1	CpDpCtD
Amantadine—DRD2—Bromocriptine—type 2 diabetes mellitus	0.0365	0.187	CbGbCtD
Amantadine—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0316	0.162	CbGbCtD
Amantadine—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0282	0.144	CbGbCtD
Amantadine—SLC22A2—Metformin—type 2 diabetes mellitus	0.0237	0.122	CbGbCtD
Amantadine—SLC22A1—Metformin—type 2 diabetes mellitus	0.0206	0.106	CbGbCtD
Amantadine—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0204	0.104	CbGbCtD
Amantadine—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.014	0.0718	CbGbCtD
Amantadine—ABCB1—Glyburide—type 2 diabetes mellitus	0.0104	0.0535	CbGbCtD
Amantadine—ABCB1—Losartan—type 2 diabetes mellitus	0.00953	0.0489	CbGbCtD
Amantadine—GRIN2C—nerve—type 2 diabetes mellitus	0.0038	0.136	CbGeAlD
Amantadine—GRIN2B—nerve—type 2 diabetes mellitus	0.003	0.108	CbGeAlD
Amantadine—GRIN2A—nerve—type 2 diabetes mellitus	0.00263	0.0943	CbGeAlD
Amantadine—DDC—nerve—type 2 diabetes mellitus	0.00245	0.0881	CbGeAlD
Amantadine—MAOB—nerve—type 2 diabetes mellitus	0.00126	0.0453	CbGeAlD
Amantadine—DRD2—nerve—type 2 diabetes mellitus	0.00107	0.0382	CbGeAlD
Amantadine—DDC—nephron tubule—type 2 diabetes mellitus	0.000957	0.0344	CbGeAlD
Amantadine—DDC—kidney—type 2 diabetes mellitus	0.000841	0.0302	CbGeAlD
Amantadine—DDC—cortex of kidney—type 2 diabetes mellitus	0.000819	0.0294	CbGeAlD
Amantadine—SLC22A2—nephron tubule—type 2 diabetes mellitus	0.000788	0.0283	CbGeAlD
Amantadine—SLC22A2—kidney—type 2 diabetes mellitus	0.000693	0.0249	CbGeAlD
Amantadine—SLC22A2—cortex of kidney—type 2 diabetes mellitus	0.000675	0.0242	CbGeAlD
Amantadine—SIGMAR1—islet of Langerhans—type 2 diabetes mellitus	0.000639	0.0229	CbGeAlD
Amantadine—DDC—liver—type 2 diabetes mellitus	0.000532	0.0191	CbGeAlD
Amantadine—SIGMAR1—nephron tubule—type 2 diabetes mellitus	0.000514	0.0185	CbGeAlD
Amantadine—MAOB—nephron tubule—type 2 diabetes mellitus	0.000492	0.0177	CbGeAlD
Amantadine—SLC22A1—kidney—type 2 diabetes mellitus	0.000489	0.0176	CbGeAlD
Amantadine—SIGMAR1—pancreas—type 2 diabetes mellitus	0.000449	0.0161	CbGeAlD
Amantadine—MAOB—cardiovascular system—type 2 diabetes mellitus	0.000442	0.0159	CbGeAlD
Amantadine—DRD2—retina—type 2 diabetes mellitus	0.000441	0.0158	CbGeAlD
Amantadine—SLC22A1—adipose tissue—type 2 diabetes mellitus	0.000441	0.0158	CbGeAlD
Amantadine—SIGMAR1—cortex of kidney—type 2 diabetes mellitus	0.00044	0.0158	CbGeAlD
Amantadine—MAOB—kidney—type 2 diabetes mellitus	0.000433	0.0155	CbGeAlD
Amantadine—MAOB—cortex of kidney—type 2 diabetes mellitus	0.000421	0.0151	CbGeAlD
Amantadine—SIGMAR1—adipose tissue—type 2 diabetes mellitus	0.000407	0.0146	CbGeAlD
Amantadine—MAOB—adipose tissue—type 2 diabetes mellitus	0.00039	0.014	CbGeAlD
Amantadine—SLC22A1—liver—type 2 diabetes mellitus	0.000309	0.0111	CbGeAlD
Amantadine—SIGMAR1—liver—type 2 diabetes mellitus	0.000286	0.0103	CbGeAlD
Amantadine—MAOB—liver—type 2 diabetes mellitus	0.000273	0.00982	CbGeAlD
Amantadine—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000223	0.00801	CbGeAlD
Amantadine—ABCB1—retina—type 2 diabetes mellitus	0.000191	0.00685	CbGeAlD
Amantadine—ABCB1—nephron tubule—type 2 diabetes mellitus	0.00018	0.00645	CbGeAlD
Amantadine—ABCB1—cardiovascular system—type 2 diabetes mellitus	0.000161	0.00579	CbGeAlD
Amantadine—ABCB1—kidney—type 2 diabetes mellitus	0.000158	0.00567	CbGeAlD
Amantadine—ABCB1—pancreas—type 2 diabetes mellitus	0.000157	0.00563	CbGeAlD
Amantadine—ABCB1—cortex of kidney—type 2 diabetes mellitus	0.000154	0.00552	CbGeAlD
Amantadine—ABCB1—adipose tissue—type 2 diabetes mellitus	0.000142	0.00511	CbGeAlD
Amantadine—Oedema—Valsartan—type 2 diabetes mellitus	0.000127	0.00085	CcSEcCtD
Amantadine—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000127	0.000849	CcSEcCtD
Amantadine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000127	0.000848	CcSEcCtD
Amantadine—Rash—Glipizide—type 2 diabetes mellitus	0.000126	0.000844	CcSEcCtD
Amantadine—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000126	0.000844	CcSEcCtD
Amantadine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000126	0.000843	CcSEcCtD
Amantadine—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000126	0.00084	CcSEcCtD
Amantadine—Oedema—Orlistat—type 2 diabetes mellitus	0.000126	0.00084	CcSEcCtD
Amantadine—Headache—Glipizide—type 2 diabetes mellitus	0.000125	0.000839	CcSEcCtD
Amantadine—Tremor—Irbesartan—type 2 diabetes mellitus	0.000125	0.000839	CcSEcCtD
Amantadine—Palpitations—Metformin—type 2 diabetes mellitus	0.000125	0.000838	CcSEcCtD
Amantadine—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000125	0.000837	CcSEcCtD
Amantadine—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000125	0.000834	CcSEcCtD
Amantadine—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000124	0.000831	CcSEcCtD
Amantadine—Tension—Losartan—type 2 diabetes mellitus	0.000124	0.000827	CcSEcCtD
Amantadine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000123	0.000826	CcSEcCtD
Amantadine—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000123	0.000826	CcSEcCtD
Amantadine—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000123	0.000825	CcSEcCtD
Amantadine—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000123	0.000824	CcSEcCtD
Amantadine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000123	0.000824	CcSEcCtD
Amantadine—Agitation—Irbesartan—type 2 diabetes mellitus	0.000123	0.000823	CcSEcCtD
Amantadine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000123	0.000822	CcSEcCtD
Amantadine—Hypertension—Metformin—type 2 diabetes mellitus	0.000122	0.000819	CcSEcCtD
Amantadine—Nervousness—Losartan—type 2 diabetes mellitus	0.000122	0.000818	CcSEcCtD
Amantadine—Oedema peripheral—Ramipril—type 2 diabetes mellitus	0.000122	0.000817	CcSEcCtD
Amantadine—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000122	0.000816	CcSEcCtD
Amantadine—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000122	0.000814	CcSEcCtD
Amantadine—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000121	0.000812	CcSEcCtD
Amantadine—Anorexia—Valsartan—type 2 diabetes mellitus	0.000121	0.00081	CcSEcCtD
Amantadine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000121	0.000809	CcSEcCtD
Amantadine—Headache—Pioglitazone—type 2 diabetes mellitus	0.00012	0.000803	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.00012	0.000802	CcSEcCtD
Amantadine—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.00012	0.000801	CcSEcCtD
Amantadine—Visual impairment—Ramipril—type 2 diabetes mellitus	0.00012	0.0008	CcSEcCtD
Amantadine—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000119	0.000799	CcSEcCtD
Amantadine—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000119	0.000798	CcSEcCtD
Amantadine—Nausea—Glipizide—type 2 diabetes mellitus	0.000119	0.000795	CcSEcCtD
Amantadine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000119	0.000794	CcSEcCtD
Amantadine—Hypotension—Valsartan—type 2 diabetes mellitus	0.000119	0.000794	CcSEcCtD
Amantadine—Vision blurred—Losartan—type 2 diabetes mellitus	0.000119	0.000794	CcSEcCtD
Amantadine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000118	0.000792	CcSEcCtD
Amantadine—Constipation—Gliclazide—type 2 diabetes mellitus	0.000118	0.000791	CcSEcCtD
Amantadine—Tremor—Losartan—type 2 diabetes mellitus	0.000118	0.000789	CcSEcCtD
Amantadine—Rash—Glimepiride—type 2 diabetes mellitus	0.000118	0.000788	CcSEcCtD
Amantadine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000118	0.000787	CcSEcCtD
Amantadine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000117	0.000785	CcSEcCtD
Amantadine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000117	0.000785	CcSEcCtD
Amantadine—Headache—Glimepiride—type 2 diabetes mellitus	0.000117	0.000783	CcSEcCtD
Amantadine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000117	0.00078	CcSEcCtD
Amantadine—Agitation—Losartan—type 2 diabetes mellitus	0.000116	0.000774	CcSEcCtD
Amantadine—Oedema—Metformin—type 2 diabetes mellitus	0.000116	0.000774	CcSEcCtD
Amantadine—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000116	0.000773	CcSEcCtD
Amantadine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000115	0.000771	CcSEcCtD
Amantadine—Insomnia—Valsartan—type 2 diabetes mellitus	0.000115	0.000769	CcSEcCtD
Amantadine—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000114	0.000763	CcSEcCtD
Amantadine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000114	0.000762	CcSEcCtD
Amantadine—Insomnia—Orlistat—type 2 diabetes mellitus	0.000114	0.00076	CcSEcCtD
Amantadine—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000114	0.000759	CcSEcCtD
Amantadine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000113	0.000759	CcSEcCtD
Amantadine—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000113	0.000759	CcSEcCtD
Amantadine—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000113	0.000758	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000113	0.000757	CcSEcCtD
Amantadine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000113	0.000756	CcSEcCtD
Amantadine—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000113	0.000754	CcSEcCtD
Amantadine—Leukopenia—Losartan—type 2 diabetes mellitus	0.000113	0.000754	CcSEcCtD
Amantadine—Skin disorder—Metformin—type 2 diabetes mellitus	0.000112	0.000752	CcSEcCtD
Amantadine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000112	0.000748	CcSEcCtD
Amantadine—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000112	0.000748	CcSEcCtD
Amantadine—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000112	0.000748	CcSEcCtD
Amantadine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000111	0.000745	CcSEcCtD
Amantadine—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000111	0.000745	CcSEcCtD
Amantadine—Palpitations—Losartan—type 2 diabetes mellitus	0.000111	0.000744	CcSEcCtD
Amantadine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000111	0.000742	CcSEcCtD
Amantadine—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000111	0.000741	CcSEcCtD
Amantadine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000111	0.00074	CcSEcCtD
Amantadine—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000111	0.000739	CcSEcCtD
Amantadine—Asthenia—Glyburide—type 2 diabetes mellitus	0.000111	0.000739	CcSEcCtD
Amantadine—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.00011	0.000739	CcSEcCtD
Amantadine—Anorexia—Metformin—type 2 diabetes mellitus	0.00011	0.000738	CcSEcCtD
Amantadine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.00011	0.000734	CcSEcCtD
Amantadine—Alopecia—Ramipril—type 2 diabetes mellitus	0.00011	0.000733	CcSEcCtD
Amantadine—Fatigue—Valsartan—type 2 diabetes mellitus	0.00011	0.000733	CcSEcCtD
Amantadine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000109	0.000731	CcSEcCtD
Amantadine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000109	0.00073	CcSEcCtD
Amantadine—Oedema—Irbesartan—type 2 diabetes mellitus	0.000109	0.00073	CcSEcCtD
Amantadine—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000109	0.00073	CcSEcCtD
Amantadine—Pruritus—Glyburide—type 2 diabetes mellitus	0.000109	0.000729	CcSEcCtD
Amantadine—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000109	0.000727	CcSEcCtD
Amantadine—Constipation—Valsartan—type 2 diabetes mellitus	0.000109	0.000727	CcSEcCtD
Amantadine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000108	0.000725	CcSEcCtD
Amantadine—Fatigue—Orlistat—type 2 diabetes mellitus	0.000108	0.000724	CcSEcCtD
Amantadine—Hypotension—Metformin—type 2 diabetes mellitus	0.000108	0.000723	CcSEcCtD
Amantadine—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000108	0.000722	CcSEcCtD
Amantadine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000107	0.000717	CcSEcCtD
Amantadine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000107	0.000716	CcSEcCtD
Amantadine—Anxiety—Losartan—type 2 diabetes mellitus	0.000107	0.000715	CcSEcCtD
Amantadine—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000107	0.000713	CcSEcCtD
Amantadine—Rash—Bromocriptine—type 2 diabetes mellitus	0.000106	0.000711	CcSEcCtD
Amantadine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000106	0.00071	CcSEcCtD
Amantadine—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000106	0.00071	CcSEcCtD
Amantadine—Tension—Ramipril—type 2 diabetes mellitus	0.000106	0.000709	CcSEcCtD
Amantadine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000106	0.000706	CcSEcCtD
Amantadine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000106	0.000706	CcSEcCtD
Amantadine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000105	0.000705	CcSEcCtD
Amantadine—Nervousness—Ramipril—type 2 diabetes mellitus	0.000105	0.000702	CcSEcCtD
Amantadine—Dry mouth—Losartan—type 2 diabetes mellitus	0.000105	0.000701	CcSEcCtD
Amantadine—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000104	0.000696	CcSEcCtD
Amantadine—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000104	0.000695	CcSEcCtD
Amantadine—Confusional state—Losartan—type 2 diabetes mellitus	0.000104	0.000693	CcSEcCtD
Amantadine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000103	0.000692	CcSEcCtD
Amantadine—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000103	0.00069	CcSEcCtD
Amantadine—Somnolence—Metformin—type 2 diabetes mellitus	0.000103	0.000688	CcSEcCtD
Amantadine—Oedema—Losartan—type 2 diabetes mellitus	0.000103	0.000687	CcSEcCtD
Amantadine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000103	0.000687	CcSEcCtD
Amantadine—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000102	0.000683	CcSEcCtD
Amantadine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000102	0.000682	CcSEcCtD
Amantadine—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000102	0.000681	CcSEcCtD
Amantadine—Tremor—Ramipril—type 2 diabetes mellitus	0.000101	0.000677	CcSEcCtD
Amantadine—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000101	0.000674	CcSEcCtD
Amantadine—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000101	0.000673	CcSEcCtD
Amantadine—Tachycardia—Losartan—type 2 diabetes mellitus	0.0001	0.000671	CcSEcCtD
Amantadine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.0001	0.000669	CcSEcCtD
Amantadine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	9.99e-05	0.000668	CcSEcCtD
Amantadine—Fatigue—Metformin—type 2 diabetes mellitus	9.98e-05	0.000667	CcSEcCtD
Amantadine—ABCB1—liver—type 2 diabetes mellitus	9.97e-05	0.00358	CbGeAlD
Amantadine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	9.93e-05	0.000665	CcSEcCtD
Amantadine—Body temperature increased—Orlistat—type 2 diabetes mellitus	9.93e-05	0.000664	CcSEcCtD
Amantadine—Asthenia—Gliclazide—type 2 diabetes mellitus	9.92e-05	0.000664	CcSEcCtD
Amantadine—Agitation—Ramipril—type 2 diabetes mellitus	9.92e-05	0.000664	CcSEcCtD
Amantadine—Constipation—Metformin—type 2 diabetes mellitus	9.89e-05	0.000662	CcSEcCtD
Amantadine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	9.8e-05	0.000656	CcSEcCtD
Amantadine—Anorexia—Losartan—type 2 diabetes mellitus	9.8e-05	0.000655	CcSEcCtD
Amantadine—Vomiting—Glyburide—type 2 diabetes mellitus	9.79e-05	0.000655	CcSEcCtD
Amantadine—Pruritus—Gliclazide—type 2 diabetes mellitus	9.78e-05	0.000655	CcSEcCtD
Amantadine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	9.73e-05	0.000651	CcSEcCtD
Amantadine—Rash—Glyburide—type 2 diabetes mellitus	9.71e-05	0.00065	CcSEcCtD
Amantadine—Somnolence—Irbesartan—type 2 diabetes mellitus	9.71e-05	0.000649	CcSEcCtD
Amantadine—Dermatitis—Glyburide—type 2 diabetes mellitus	9.7e-05	0.000649	CcSEcCtD
Amantadine—Leukopenia—Ramipril—type 2 diabetes mellitus	9.66e-05	0.000647	CcSEcCtD
Amantadine—Headache—Glyburide—type 2 diabetes mellitus	9.65e-05	0.000645	CcSEcCtD
Amantadine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	9.61e-05	0.000643	CcSEcCtD
Amantadine—Hypotension—Losartan—type 2 diabetes mellitus	9.6e-05	0.000642	CcSEcCtD
Amantadine—Palpitations—Ramipril—type 2 diabetes mellitus	9.54e-05	0.000638	CcSEcCtD
Amantadine—Feeling abnormal—Metformin—type 2 diabetes mellitus	9.53e-05	0.000638	CcSEcCtD
Amantadine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	9.49e-05	0.000635	CcSEcCtD
Amantadine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	9.46e-05	0.000633	CcSEcCtD
Amantadine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	9.43e-05	0.000631	CcSEcCtD
Amantadine—Fatigue—Irbesartan—type 2 diabetes mellitus	9.41e-05	0.00063	CcSEcCtD
Amantadine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	9.36e-05	0.000626	CcSEcCtD
Amantadine—Convulsion—Ramipril—type 2 diabetes mellitus	9.35e-05	0.000626	CcSEcCtD
Amantadine—Constipation—Irbesartan—type 2 diabetes mellitus	9.34e-05	0.000625	CcSEcCtD
Amantadine—Insomnia—Losartan—type 2 diabetes mellitus	9.29e-05	0.000622	CcSEcCtD
Amantadine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	9.25e-05	0.000619	CcSEcCtD
Amantadine—Paraesthesia—Losartan—type 2 diabetes mellitus	9.23e-05	0.000617	CcSEcCtD
Amantadine—Dyspnoea—Losartan—type 2 diabetes mellitus	9.16e-05	0.000613	CcSEcCtD
Amantadine—Anxiety—Ramipril—type 2 diabetes mellitus	9.16e-05	0.000613	CcSEcCtD
Amantadine—Nausea—Glyburide—type 2 diabetes mellitus	9.15e-05	0.000612	CcSEcCtD
Amantadine—Dizziness—Gliclazide—type 2 diabetes mellitus	9.15e-05	0.000612	CcSEcCtD
Amantadine—Somnolence—Losartan—type 2 diabetes mellitus	9.14e-05	0.000611	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	9.13e-05	0.000611	CcSEcCtD
Amantadine—Asthenia—Valsartan—type 2 diabetes mellitus	9.12e-05	0.00061	CcSEcCtD
Amantadine—Dyspepsia—Losartan—type 2 diabetes mellitus	9.05e-05	0.000605	CcSEcCtD
Amantadine—Asthenia—Orlistat—type 2 diabetes mellitus	9.01e-05	0.000603	CcSEcCtD
Amantadine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	9e-05	0.000602	CcSEcCtD
Amantadine—Pruritus—Valsartan—type 2 diabetes mellitus	8.99e-05	0.000601	CcSEcCtD
Amantadine—Dry mouth—Ramipril—type 2 diabetes mellitus	8.99e-05	0.000601	CcSEcCtD
Amantadine—Decreased appetite—Losartan—type 2 diabetes mellitus	8.93e-05	0.000598	CcSEcCtD
Amantadine—Confusional state—Ramipril—type 2 diabetes mellitus	8.88e-05	0.000594	CcSEcCtD
Amantadine—Pruritus—Orlistat—type 2 diabetes mellitus	8.88e-05	0.000594	CcSEcCtD
Amantadine—Fatigue—Losartan—type 2 diabetes mellitus	8.86e-05	0.000593	CcSEcCtD
Amantadine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	8.81e-05	0.000589	CcSEcCtD
Amantadine—Oedema—Ramipril—type 2 diabetes mellitus	8.81e-05	0.000589	CcSEcCtD
Amantadine—Vomiting—Gliclazide—type 2 diabetes mellitus	8.79e-05	0.000588	CcSEcCtD
Amantadine—Constipation—Losartan—type 2 diabetes mellitus	8.79e-05	0.000588	CcSEcCtD
Amantadine—Rash—Gliclazide—type 2 diabetes mellitus	8.72e-05	0.000583	CcSEcCtD
Amantadine—Dermatitis—Gliclazide—type 2 diabetes mellitus	8.71e-05	0.000583	CcSEcCtD
Amantadine—Diarrhoea—Valsartan—type 2 diabetes mellitus	8.69e-05	0.000582	CcSEcCtD
Amantadine—Headache—Gliclazide—type 2 diabetes mellitus	8.66e-05	0.00058	CcSEcCtD
Amantadine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	8.64e-05	0.000578	CcSEcCtD
Amantadine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	8.63e-05	0.000577	CcSEcCtD
Amantadine—Tachycardia—Ramipril—type 2 diabetes mellitus	8.6e-05	0.000575	CcSEcCtD
Amantadine—Diarrhoea—Orlistat—type 2 diabetes mellitus	8.59e-05	0.000575	CcSEcCtD
Amantadine—Skin disorder—Ramipril—type 2 diabetes mellitus	8.56e-05	0.000573	CcSEcCtD
Amantadine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	8.52e-05	0.00057	CcSEcCtD
Amantadine—Feeling abnormal—Losartan—type 2 diabetes mellitus	8.47e-05	0.000567	CcSEcCtD
Amantadine—Dizziness—Valsartan—type 2 diabetes mellitus	8.4e-05	0.000562	CcSEcCtD
Amantadine—Anorexia—Ramipril—type 2 diabetes mellitus	8.4e-05	0.000562	CcSEcCtD
Amantadine—Dizziness—Orlistat—type 2 diabetes mellitus	8.3e-05	0.000555	CcSEcCtD
Amantadine—Asthenia—Metformin—type 2 diabetes mellitus	8.3e-05	0.000555	CcSEcCtD
Amantadine—Hypotension—Ramipril—type 2 diabetes mellitus	8.23e-05	0.000551	CcSEcCtD
Amantadine—Nausea—Gliclazide—type 2 diabetes mellitus	8.21e-05	0.00055	CcSEcCtD
Amantadine—Pruritus—Metformin—type 2 diabetes mellitus	8.19e-05	0.000548	CcSEcCtD
Amantadine—Body temperature increased—Losartan—type 2 diabetes mellitus	8.12e-05	0.000543	CcSEcCtD
Amantadine—Vomiting—Valsartan—type 2 diabetes mellitus	8.08e-05	0.00054	CcSEcCtD
Amantadine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	8.04e-05	0.000538	CcSEcCtD
Amantadine—Rash—Valsartan—type 2 diabetes mellitus	8.01e-05	0.000536	CcSEcCtD
Amantadine—Dermatitis—Valsartan—type 2 diabetes mellitus	8e-05	0.000535	CcSEcCtD
Amantadine—Vomiting—Orlistat—type 2 diabetes mellitus	7.98e-05	0.000534	CcSEcCtD
Amantadine—Insomnia—Ramipril—type 2 diabetes mellitus	7.97e-05	0.000533	CcSEcCtD
Amantadine—Headache—Valsartan—type 2 diabetes mellitus	7.96e-05	0.000533	CcSEcCtD
Amantadine—Diarrhoea—Metformin—type 2 diabetes mellitus	7.92e-05	0.00053	CcSEcCtD
Amantadine—Rash—Orlistat—type 2 diabetes mellitus	7.92e-05	0.00053	CcSEcCtD
Amantadine—Paraesthesia—Ramipril—type 2 diabetes mellitus	7.91e-05	0.000529	CcSEcCtD
Amantadine—Dermatitis—Orlistat—type 2 diabetes mellitus	7.91e-05	0.000529	CcSEcCtD
Amantadine—Headache—Orlistat—type 2 diabetes mellitus	7.87e-05	0.000526	CcSEcCtD
Amantadine—Dyspnoea—Ramipril—type 2 diabetes mellitus	7.86e-05	0.000526	CcSEcCtD
Amantadine—Asthenia—Irbesartan—type 2 diabetes mellitus	7.83e-05	0.000524	CcSEcCtD
Amantadine—Somnolence—Ramipril—type 2 diabetes mellitus	7.83e-05	0.000524	CcSEcCtD
Amantadine—Dyspepsia—Ramipril—type 2 diabetes mellitus	7.76e-05	0.000519	CcSEcCtD
Amantadine—Pruritus—Irbesartan—type 2 diabetes mellitus	7.73e-05	0.000517	CcSEcCtD
Amantadine—Decreased appetite—Ramipril—type 2 diabetes mellitus	7.66e-05	0.000512	CcSEcCtD
Amantadine—Dizziness—Metformin—type 2 diabetes mellitus	7.65e-05	0.000512	CcSEcCtD
Amantadine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	7.61e-05	0.000509	CcSEcCtD
Amantadine—Fatigue—Ramipril—type 2 diabetes mellitus	7.6e-05	0.000508	CcSEcCtD
Amantadine—Hypersensitivity—Losartan—type 2 diabetes mellitus	7.57e-05	0.000506	CcSEcCtD
Amantadine—Nausea—Valsartan—type 2 diabetes mellitus	7.55e-05	0.000505	CcSEcCtD
Amantadine—Constipation—Ramipril—type 2 diabetes mellitus	7.53e-05	0.000504	CcSEcCtD
Amantadine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	7.47e-05	0.0005	CcSEcCtD
Amantadine—Nausea—Orlistat—type 2 diabetes mellitus	7.46e-05	0.000499	CcSEcCtD
Amantadine—Asthenia—Losartan—type 2 diabetes mellitus	7.37e-05	0.000493	CcSEcCtD
Amantadine—Vomiting—Metformin—type 2 diabetes mellitus	7.36e-05	0.000492	CcSEcCtD
Amantadine—Rash—Metformin—type 2 diabetes mellitus	7.3e-05	0.000488	CcSEcCtD
Amantadine—Dermatitis—Metformin—type 2 diabetes mellitus	7.29e-05	0.000488	CcSEcCtD
Amantadine—Pruritus—Losartan—type 2 diabetes mellitus	7.27e-05	0.000486	CcSEcCtD
Amantadine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	7.26e-05	0.000486	CcSEcCtD
Amantadine—Headache—Metformin—type 2 diabetes mellitus	7.25e-05	0.000485	CcSEcCtD
Amantadine—Dizziness—Irbesartan—type 2 diabetes mellitus	7.22e-05	0.000483	CcSEcCtD
Amantadine—Diarrhoea—Losartan—type 2 diabetes mellitus	7.03e-05	0.00047	CcSEcCtD
Amantadine—Body temperature increased—Ramipril—type 2 diabetes mellitus	6.97e-05	0.000466	CcSEcCtD
Amantadine—Vomiting—Irbesartan—type 2 diabetes mellitus	6.94e-05	0.000464	CcSEcCtD
Amantadine—Rash—Irbesartan—type 2 diabetes mellitus	6.88e-05	0.000461	CcSEcCtD
Amantadine—Dermatitis—Irbesartan—type 2 diabetes mellitus	6.88e-05	0.00046	CcSEcCtD
Amantadine—Nausea—Metformin—type 2 diabetes mellitus	6.87e-05	0.00046	CcSEcCtD
Amantadine—Headache—Irbesartan—type 2 diabetes mellitus	6.84e-05	0.000458	CcSEcCtD
Amantadine—Dizziness—Losartan—type 2 diabetes mellitus	6.8e-05	0.000455	CcSEcCtD
Amantadine—Vomiting—Losartan—type 2 diabetes mellitus	6.53e-05	0.000437	CcSEcCtD
Amantadine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	6.49e-05	0.000434	CcSEcCtD
Amantadine—Nausea—Irbesartan—type 2 diabetes mellitus	6.49e-05	0.000434	CcSEcCtD
Amantadine—Rash—Losartan—type 2 diabetes mellitus	6.48e-05	0.000433	CcSEcCtD
Amantadine—Dermatitis—Losartan—type 2 diabetes mellitus	6.47e-05	0.000433	CcSEcCtD
Amantadine—Headache—Losartan—type 2 diabetes mellitus	6.44e-05	0.000431	CcSEcCtD
Amantadine—Asthenia—Ramipril—type 2 diabetes mellitus	6.32e-05	0.000423	CcSEcCtD
Amantadine—Pruritus—Ramipril—type 2 diabetes mellitus	6.23e-05	0.000417	CcSEcCtD
Amantadine—Nausea—Losartan—type 2 diabetes mellitus	6.1e-05	0.000408	CcSEcCtD
Amantadine—Diarrhoea—Ramipril—type 2 diabetes mellitus	6.03e-05	0.000403	CcSEcCtD
Amantadine—Dizziness—Ramipril—type 2 diabetes mellitus	5.83e-05	0.00039	CcSEcCtD
Amantadine—Vomiting—Ramipril—type 2 diabetes mellitus	5.6e-05	0.000375	CcSEcCtD
Amantadine—Rash—Ramipril—type 2 diabetes mellitus	5.56e-05	0.000372	CcSEcCtD
Amantadine—Dermatitis—Ramipril—type 2 diabetes mellitus	5.55e-05	0.000371	CcSEcCtD
Amantadine—Headache—Ramipril—type 2 diabetes mellitus	5.52e-05	0.000369	CcSEcCtD
Amantadine—Nausea—Ramipril—type 2 diabetes mellitus	5.23e-05	0.00035	CcSEcCtD
Amantadine—ABCB1—Metabolism—ABCC8—type 2 diabetes mellitus	7.74e-06	8.64e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CBS—type 2 diabetes mellitus	7.74e-06	8.64e-05	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—IL6—type 2 diabetes mellitus	7.74e-06	8.64e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	7.7e-06	8.6e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—NOS3—type 2 diabetes mellitus	7.63e-06	8.53e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—PIK3R1—type 2 diabetes mellitus	7.63e-06	8.53e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	7.63e-06	8.52e-05	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	7.61e-06	8.5e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—ADRA2A—type 2 diabetes mellitus	7.59e-06	8.48e-05	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—AKT1—type 2 diabetes mellitus	7.58e-06	8.47e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	7.56e-06	8.44e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—SPRY2—type 2 diabetes mellitus	7.56e-06	8.44e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—PPARG—type 2 diabetes mellitus	7.47e-06	8.34e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—COX2—type 2 diabetes mellitus	7.45e-06	8.32e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—SLC5A2—type 2 diabetes mellitus	7.45e-06	8.32e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—GNB3—type 2 diabetes mellitus	7.45e-06	8.32e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—SNAP25—type 2 diabetes mellitus	7.44e-06	8.31e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PSMD6—type 2 diabetes mellitus	7.44e-06	8.31e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—SREBF1—type 2 diabetes mellitus	7.44e-06	8.31e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	7.41e-06	8.27e-05	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—AKT1—type 2 diabetes mellitus	7.39e-06	8.25e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—RBP4—type 2 diabetes mellitus	7.36e-06	8.23e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—GLP1R—type 2 diabetes mellitus	7.36e-06	8.23e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—AVP—type 2 diabetes mellitus	7.35e-06	8.21e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—MMP3—type 2 diabetes mellitus	7.35e-06	8.21e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—INS—type 2 diabetes mellitus	7.32e-06	8.18e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—NCOA6—type 2 diabetes mellitus	7.32e-06	8.17e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	7.31e-06	8.17e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CTGF—type 2 diabetes mellitus	7.3e-06	8.15e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CYP2E1—type 2 diabetes mellitus	7.3e-06	8.15e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CCKAR—type 2 diabetes mellitus	7.25e-06	8.09e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—HMGCR—type 2 diabetes mellitus	7.23e-06	8.08e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—SLC2A1—type 2 diabetes mellitus	7.22e-06	8.06e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CYP1A2—type 2 diabetes mellitus	7.22e-06	8.06e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	7.21e-06	8.06e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—HSD11B1—type 2 diabetes mellitus	7.19e-06	8.04e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—UCP3—type 2 diabetes mellitus	7.19e-06	8.04e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—UCP2—type 2 diabetes mellitus	7.19e-06	8.04e-05	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	7.09e-06	7.92e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—ADRA2A—type 2 diabetes mellitus	7.08e-06	7.91e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CYP3A4—type 2 diabetes mellitus	7.04e-06	7.86e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—EDN1—type 2 diabetes mellitus	6.99e-06	7.81e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—PTGS2—type 2 diabetes mellitus	6.98e-06	7.8e-05	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	6.95e-06	7.77e-05	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	6.92e-06	7.73e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GCG—type 2 diabetes mellitus	6.92e-06	7.73e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—SLC2A4—type 2 diabetes mellitus	6.92e-06	7.73e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	6.88e-06	7.69e-05	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	6.86e-06	7.66e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CYP2E1—type 2 diabetes mellitus	6.8e-06	7.6e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PCK1—type 2 diabetes mellitus	6.76e-06	7.56e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CYP1A2—type 2 diabetes mellitus	6.72e-06	7.51e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—SLC2A1—type 2 diabetes mellitus	6.72e-06	7.51e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—C3—type 2 diabetes mellitus	6.72e-06	7.51e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—ALB—type 2 diabetes mellitus	6.72e-06	7.5e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	6.64e-06	7.42e-05	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	6.63e-06	7.41e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	6.62e-06	7.4e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	6.56e-06	7.33e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CYP3A4—type 2 diabetes mellitus	6.56e-06	7.33e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—IAPP—type 2 diabetes mellitus	6.52e-06	7.29e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	6.49e-06	7.25e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—INSR—type 2 diabetes mellitus	6.48e-06	7.24e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GCG—type 2 diabetes mellitus	6.45e-06	7.2e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—SLC2A4—type 2 diabetes mellitus	6.45e-06	7.2e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—PIK3R1—type 2 diabetes mellitus	6.42e-06	7.18e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—NOS3—type 2 diabetes mellitus	6.42e-06	7.18e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—AGT—type 2 diabetes mellitus	6.39e-06	7.14e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—TRPC6—type 2 diabetes mellitus	6.37e-06	7.12e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	6.36e-06	7.11e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—HK1—type 2 diabetes mellitus	6.33e-06	7.08e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—AGTR2—type 2 diabetes mellitus	6.33e-06	7.07e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—CCR5—type 2 diabetes mellitus	6.25e-06	6.98e-05	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	6.2e-06	6.92e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	6.18e-06	6.91e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GCKR—type 2 diabetes mellitus	6.12e-06	6.83e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—LPA—type 2 diabetes mellitus	6.12e-06	6.83e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—KCNJ11—type 2 diabetes mellitus	6.12e-06	6.83e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—HSD3B2—type 2 diabetes mellitus	6.12e-06	6.83e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—C3—type 2 diabetes mellitus	6.11e-06	6.82e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—EDNRB—type 2 diabetes mellitus	6.06e-06	6.78e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.96e-06	6.66e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GNB3—type 2 diabetes mellitus	5.96e-06	6.66e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—HMOX1—type 2 diabetes mellitus	5.93e-06	6.63e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	5.9e-06	6.59e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	5.89e-06	6.58e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	5.89e-06	6.58e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—PTGS2—type 2 diabetes mellitus	5.87e-06	6.56e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—ALDOB—type 2 diabetes mellitus	5.86e-06	6.55e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CAT—type 2 diabetes mellitus	5.86e-06	6.54e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—AGT—type 2 diabetes mellitus	5.8e-06	6.48e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	5.73e-06	6.4e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	5.7e-06	6.37e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CYBA—type 2 diabetes mellitus	5.7e-06	6.37e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—APOB—type 2 diabetes mellitus	5.68e-06	6.35e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	5.6e-06	6.26e-05	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	5.59e-06	6.25e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PLAT—type 2 diabetes mellitus	5.58e-06	6.24e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—GHRL—type 2 diabetes mellitus	5.58e-06	6.24e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GNB3—type 2 diabetes mellitus	5.56e-06	6.21e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.56e-06	6.21e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—HMOX1—type 2 diabetes mellitus	5.53e-06	6.18e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GSTM1—type 2 diabetes mellitus	5.53e-06	6.18e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CALCA—type 2 diabetes mellitus	5.51e-06	6.16e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CAT—type 2 diabetes mellitus	5.46e-06	6.1e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GLP1R—type 2 diabetes mellitus	5.45e-06	6.09e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—LPL—type 2 diabetes mellitus	5.43e-06	6.06e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	5.36e-06	5.99e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—ADCY5—type 2 diabetes mellitus	5.31e-06	5.94e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—APOB—type 2 diabetes mellitus	5.3e-06	5.92e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GPX1—type 2 diabetes mellitus	5.3e-06	5.92e-05	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	5.25e-06	5.86e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	5.19e-06	5.8e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	5.17e-06	5.77e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CD36—type 2 diabetes mellitus	5.16e-06	5.76e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GSTM1—type 2 diabetes mellitus	5.15e-06	5.76e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—GCG—type 2 diabetes mellitus	5.1e-06	5.7e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	5.1e-06	5.7e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PPP2CA—type 2 diabetes mellitus	5.09e-06	5.69e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	5.09e-06	5.69e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—LPL—type 2 diabetes mellitus	5.06e-06	5.65e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	5.02e-06	5.61e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	5.01e-06	5.59e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	4.99e-06	5.57e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	4.99e-06	5.57e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—ADCY5—type 2 diabetes mellitus	4.95e-06	5.53e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GPX1—type 2 diabetes mellitus	4.94e-06	5.51e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	4.89e-06	5.46e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—MTHFR—type 2 diabetes mellitus	4.89e-06	5.46e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	4.86e-06	5.43e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	4.86e-06	5.43e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	4.86e-06	5.43e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	4.83e-06	5.4e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CD36—type 2 diabetes mellitus	4.81e-06	5.37e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PPARA—type 2 diabetes mellitus	4.79e-06	5.36e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	4.78e-06	5.34e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PPP2CA—type 2 diabetes mellitus	4.75e-06	5.3e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	4.74e-06	5.3e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	4.69e-06	5.24e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	4.69e-06	5.24e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	4.69e-06	5.24e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—AGT—type 2 diabetes mellitus	4.64e-06	5.19e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	4.6e-06	5.14e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CALM1—type 2 diabetes mellitus	4.57e-06	5.1e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—MTHFR—type 2 diabetes mellitus	4.56e-06	5.09e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—APOE—type 2 diabetes mellitus	4.55e-06	5.08e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—APOA1—type 2 diabetes mellitus	4.5e-06	5.02e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PPARA—type 2 diabetes mellitus	4.47e-06	4.99e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	4.44e-06	4.96e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—GNB3—type 2 diabetes mellitus	4.4e-06	4.92e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	4.36e-06	4.87e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	4.36e-06	4.87e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	4.36e-06	4.87e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—AVP—type 2 diabetes mellitus	4.34e-06	4.85e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—MMP3—type 2 diabetes mellitus	4.34e-06	4.85e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—AGT—type 2 diabetes mellitus	4.33e-06	4.84e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—IGF2—type 2 diabetes mellitus	4.32e-06	4.83e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	4.3e-06	4.81e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	4.28e-06	4.78e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	4.26e-06	4.76e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CALM1—type 2 diabetes mellitus	4.26e-06	4.75e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—APOE—type 2 diabetes mellitus	4.24e-06	4.74e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	4.24e-06	4.74e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—APOB—type 2 diabetes mellitus	4.2e-06	4.69e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—APOA1—type 2 diabetes mellitus	4.19e-06	4.68e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	4.18e-06	4.67e-05	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	4.16e-06	4.64e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	4.15e-06	4.64e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—EDN1—type 2 diabetes mellitus	4.13e-06	4.61e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—LPL—type 2 diabetes mellitus	4.01e-06	4.47e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	3.99e-06	4.45e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PPARG—type 2 diabetes mellitus	3.96e-06	4.43e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	3.94e-06	4.4e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	3.94e-06	4.4e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.92e-06	4.38e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—INS—type 2 diabetes mellitus	3.89e-06	4.34e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	3.84e-06	4.29e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	3.78e-06	4.22e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	3.78e-06	4.22e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.76e-06	4.2e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PPARG—type 2 diabetes mellitus	3.69e-06	4.13e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.69e-06	4.12e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—INS—type 2 diabetes mellitus	3.62e-06	4.05e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—C3—type 2 diabetes mellitus	3.61e-06	4.03e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—ALB—type 2 diabetes mellitus	3.56e-06	3.98e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—AKT1—type 2 diabetes mellitus	3.51e-06	3.92e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.44e-06	3.84e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.43e-06	3.83e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—AGT—type 2 diabetes mellitus	3.43e-06	3.83e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PIK3R1—type 2 diabetes mellitus	3.41e-06	3.81e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—NOS3—type 2 diabetes mellitus	3.41e-06	3.81e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.37e-06	3.76e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—APOE—type 2 diabetes mellitus	3.36e-06	3.75e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—LEP—type 2 diabetes mellitus	3.36e-06	3.75e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—ALB—type 2 diabetes mellitus	3.32e-06	3.71e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.32e-06	3.71e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.26e-06	3.64e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	3.26e-06	3.64e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	3.24e-06	3.62e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	3.2e-06	3.57e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PIK3R1—type 2 diabetes mellitus	3.18e-06	3.55e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—NOS3—type 2 diabetes mellitus	3.18e-06	3.55e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.17e-06	3.54e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PTGS2—type 2 diabetes mellitus	3.12e-06	3.48e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	3.11e-06	3.47e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	3.02e-06	3.38e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—IRS1—type 2 diabetes mellitus	3e-06	3.35e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	2.97e-06	3.31e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—AKT1—type 2 diabetes mellitus	2.95e-06	3.3e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PTGS2—type 2 diabetes mellitus	2.91e-06	3.25e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	2.9e-06	3.24e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	2.89e-06	3.23e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—INS—type 2 diabetes mellitus	2.87e-06	3.2e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.82e-06	3.15e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	2.82e-06	3.15e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	2.78e-06	3.11e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.77e-06	3.1e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.77e-06	3.1e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.76e-06	3.08e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	2.67e-06	2.98e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.63e-06	2.94e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	2.62e-06	2.93e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	2.54e-06	2.83e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.52e-06	2.81e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.52e-06	2.81e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	2.49e-06	2.79e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	2.49e-06	2.78e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	2.46e-06	2.75e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—RELA—type 2 diabetes mellitus	2.37e-06	2.65e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	2.17e-06	2.42e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.16e-06	2.41e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.14e-06	2.39e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—INS—type 2 diabetes mellitus	2.12e-06	2.37e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.12e-06	2.37e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.02e-06	2.25e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2e-06	2.23e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.96e-06	2.19e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	1.95e-06	2.17e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.86e-06	2.08e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	1.86e-06	2.08e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.86e-06	2.08e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.81e-06	2.02e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	1.7e-06	1.9e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.66e-06	1.86e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.63e-06	1.82e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—AKT1—type 2 diabetes mellitus	1.57e-06	1.75e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—AKT1—type 2 diabetes mellitus	1.46e-06	1.63e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—IL6—type 2 diabetes mellitus	1.25e-06	1.4e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.16e-06	1.29e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	8.56e-07	9.56e-06	CbGpPWpGaD
